Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharmacy Education News
  • NBE Releases GPAT 2025...

NBE Releases GPAT 2025 Provisional Answer Keys, Recorded Responses

sheeba farhatWritten by sheeba farhat Published On 2025-05-30T09:00:26+05:30  |  Updated On 30 May 2025 9:00 AM IST
GPAT answer key
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi- The National Board of Examinations in Medical Sciences (NBEMS) has published the Recorded Response and Provisional Answer Key of the Graduate Pharmacy Aptitude Test GPAT-2025 and Question Paper with recorded responses on its official website. GPAT-2025 exam was conducted on 25th May 2025 across the country.

The recorded responses and provisional answer keys for GPAT-2025 have been published on NBEMS website. Candidates can access it at NBEMS website under GPAT 2025 webpage using their login credentials. Candidate can click on the tab labelled “Candidate Response” on this page to access the Question Paper with their recorded responses.

Candidates who wish to challenge/raise objections to a question/provisional answer key can do the same through the tab labelled “Challenge Form” on the abovementioned webpage with a non-refundable online payment of Rs. 200/- per question/challenge as processing charges.

The provisional answer keys/questions may be challenged till 01-06-2025 (till 3 PM). Only paid challenges made during the stipulated time through the challenge form will be considered. The decision of the NBEMS on the challenges shall be final and no further communication shall be entertained. NBEMS shall not inform the candidates individually about the outcome of their challenges. Challenges submitted outside this window and/or through any mode other than prescribed herein this notice shall not be entertained. Challenges or objections without a valid explanation or reference will not be considered and will be summarily discarded.

The subject matter experts will examine all the challenges received from candidates and then final answer keys for GPAT-2025 will be displayed and result will be declared based on it. No claims pertaining to the difficulty level of a question shall be entertained. This challenge can only be raised by bonafide candidates who had appeared in the examination.

The result of GPAT-2025 shall be compiled based on the final answer keys. No grievance with regard to Answer Key(s) after declaration of result of GPAT-2025 shall be entertained. The marks obtained by a candidate on the basis of the final answer keys will be considered for computation of the result of GPAT-2025 and generation of GPAT scores & merit.

Please note that GPAT-2025 is covered under the Non-Disclosure Agreement as mentioned in the Information Bulletin (Para 9.7-9.10). Candidates are advised to go through the details of the agreement for necessary compliance.

In terms of the said Non-Disclosure Agreement, “NBEMS explicitly prohibits the candidate, from reproducing, transmitting or publishing any or some contents of this exam, in whole or in part, in any form or by any means verbal or written, electronic or mechanical for any purpose whatsoever. No content of this exam must be shared with friends, acquaintances or third parties including sharing through online means or via social media.”

SCHEME OF GPAT 2025

The exam comprises 125 multiple-choice questions, with each question having 4 response options/ distractors in the English language only. Candidates are required to select the correct/best/most appropriate response/answer out of the 4 response options provided in each question. The time allotted is 3 hrs (180 minutes).

The examination shall be a multiple choice questions test delivered using computer network (CBT) as per scheme prescribed. An indicative Blueprint of the examination is as under-

S.NO

TYPE OF QUESTIONS

NO. OF QUESTIONS

MAXIMUM MARKS

1

Pharmaceutical Chemistry & Allied Subjects

38

152

2

Pharmaceutics & Allied Subjects

38

152

3

Pharmacognosy & Allied Subjects

10

40

4

Pharmacology & Allied Subjects

28

112

5

Other Subjects of B. Pharm course

11

44

TOTAL

125

500

MARKING SCHEME

There shall be a 25% negative marking for incorrect answers. No marks will be deducted for unattempted questions.

The question paper for GPAT will be divided into multiple time-bound sections. For example, if there are 5 time-bound sections* (Section A, B, C, D & E) in the question paper, each Section will have 25 questions and 36 minutes allotted for the section. Candidates would be restricted to proceed to the next section only after completion of the allotted time for the previous section, and candidates would not be allowed to review the questions/modify the responses of a section after the completion of the allotted time for that section. Questions in the next section will start automatically after the completion of the allotted time for the previous section.

Candidates are given an option to mark any question, whether attempted or not, for review, which means that the candidate has been given an option to go through these questions in a section again before the allotted time to a section ends. Candidates may note that such questions which are marked for review shall be evaluated as per the marking scheme.

S.NO

RESPONSE

MARKS

1

Correct Response

4 Marks

2

Incorrect Response

1 Mark shall be deducted

3

Unattempted Question

Zero

RESERVATIONS

Reservation of seats shall be as per the norms of the Government of India and respective State Governments as may be applicable.

In the case of Institutes run by the Central Government, the reservation would be applicable as mentioned below-

i 15% of the seats are for Scheduled Castes (SC) candidates.

ii 7.5% seats for Scheduled Tribes (ST) candidates.

iii 27% seats for Other Backward Classes (OBC) Non-Creamy Layer (NCL) candidates as per the Central List.

iv 10% of the seats for General Economically Weaker Sections (General - EWS) candidates.

Each category will have 5% reservations for the candidates with 40% or more disability as defined in Section 2 (r) and (zc) of Persons with Disabilities (RPwD) Act, 2016.

In the case of the Institutes run/aided/recognized by State Governments, the reservation policy of the respective State Governments shall be applicable.

OBC - NCL (Non-Creamy Layer) as per Central list of OBC alone are eligible to claim OBC reservation in the counseling. All OBC applicants for GPAT are accordingly advised to indicate their category as OBC in the application form only if their caste belongs to the Central list of OBCs and they fall under the non-creamy layer.

To view the official Notice, Click here : https://medicaldialogues.in/pdf_upload/nbems20251793765961jpg-288835.pdf

NBEMSNBENational Board of ExaminationsGraduate Pharmacy Aptitude TestGPAT 2025
sheeba farhat
sheeba farhat

    Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at editorial@medicaldialogues.in.

    Show Full Article
    Next Story

    Editorial

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    View All

    Journal Club Today

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    View All

    Health News Today

    Health Bulletin 30/May/2025

    Health Bulletin 30/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok